The GP news area gives primary care providers up to date information, news and developments about Moorfields Eye Hospital NHS Foundation Trust.
The Medicines and Healthcare products Regulatory Agency (MHRA) has published information stating that systemic fluoroquinolones must now only be prescribed when other commonly recommended antibiotics are inappropriate. This follows a review by the MHRA which looked at the effectiveness of current measures to reduce the identified risk of disabling and potentially long-lasting or irreversible side effects.
For more information, please see the following link: https://www.gov.uk/drug-safety-update/fluoroquinolone-antibiotics-must-now-only-be-prescribed-when-other-commonly-recommended-antibiotics-are-inappropriate
There are many fluoroquinolones available but the most commonly prescribed at Moorfields Eye Hospital include Ciprofloxacin and Moxifloxacin.
At Moorfields, fluoroquinolones will be prescribed in line with the Trust’s antimicrobial guideline to treat sight threatening infections only.
Serious side effects that have been reported are those involving tendons, muscles, joints, nerves, or mental health – in some patients, these side effects have caused long-lasting or permanent disability.
Healthcare professionals must consider and provide patients with the below information when fluoroquinolones are prescribed and supplied.
Stop taking your flouroquinolone antibiotic and contact your doctor immediately if you have the following signs of side effect:
Situations in which other antibiotics are considered to be inappropriate and where a fluoroquinolone may be indicated are where:
The pharmacy team has been receiving a high volume of calls recently from patients, stating that they cannot obtain various medications due to manufacturing problems and stock issues.
Please be aware that at present there are very limited/no UK supplies of Diamox SR® 250mg Prolonged-release Capsules – please see details below of the alternatives used at Moorfields:
Product out of stock |
Due back date |
Temporary alternatives (considered by Moorfields) |
November 2024 |
All Moorfields glaucoma patients to be transferred to acetazolamide tablets 250mg at a dose of 125mg (half a tablet) THREE times a day as suggested by the Glaucoma Service |
Last updated: July 2024